Upgrade to SI Premium - Free Trial

Intensity Therapeutics (INTS)

4.10 +0.10 (2.50%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/26)

Latest Headlines

H.C. Wainwright Reiterates Buy Rating on Intensity Therapeutics, Inc. (INTS) August 19, 2026 6:46 AM - StreetInsider NeOnc Approaches a Major Biotech Inflection Point as tomorrow’s Brain-Cancer Data is set to Collide with a Tight Float August 11, 2026 11:01 AM - StreetInsider Intensity Therapeutics, Inc. (INTS) Misses Q2 EPS by 24c August 11, 2026 8:01 AM - StreetInsider Form 8-K INTENSITY THERAPEUTICS, For: Aug 11 August 11, 2026 7:41 AM - SEC Filing Intensity Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update August 11, 2026 7:30 AM - PR NewsWire Form 10-Q INTENSITY THERAPEUTICS, For: Jun 30 August 11, 2026 7:17 AM - SEC Filing Intensity Therapeutics to Announce Second Quarter 2026 Financial Results on August 11, 2026 August 4, 2026 8:00 AM - PR NewsWire Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: DUBIN THOMAS I H July 20, 2026 4:04 PM - SEC Filing Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: Donovan Daniel July 20, 2026 4:04 PM - SEC Filing Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: GOLDBERG MARK A July 20, 2026 4:04 PM - SEC Filing Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: Leahy Emer July 20, 2026 4:03 PM - SEC Filing Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: Wesolowski John M July 20, 2026 4:03 PM - SEC Filing Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: Talamo Joseph July 20, 2026 4:03 PM - SEC Filing Form 4 INTENSITY THERAPEUTICS, For: Jul 16 Filed by: BENDER LEWIS H July 20, 2026 4:01 PM - SEC Filing Intensity Therapeutics resumes breast cancer trial in Switzerland July 15, 2026 7:45 AM - StreetInsider Intensity Therapeutics, Inc. Restarts Patient Treatment in the Randomized, Presurgical Triple Negative Breast Cancer Phase 2 Clinical Trial (INVINCIBLE-4 Study) July 15, 2026 7:45 AM - PR NewsWire Form S-8 INTENSITY THERAPEUTICS, July 8, 2026 4:01 PM - SEC Filing Form 4 INTENSITY THERAPEUTICS, For: Jun 30 Filed by: Wesolowski John M July 1, 2026 4:09 PM - SEC Filing Form 4 INTENSITY THERAPEUTICS, For: Jun 30 Filed by: Talamo Joseph July 1, 2026 4:08 PM - SEC Filing Intensity Therapeutics resumes clinical trials, pursues partners for INT230-6 July 1, 2026 8:01 AM - StreetInsider Intensity Therapeutics Provides Mid-Year Update Highlighting Late-Stage Development Programs and Strategic Partnering Opportunities for INT230-6 July 1, 2026 8:00 AM - PR NewsWire Form 8-K INTENSITY THERAPEUTICS, For: Jun 16 June 16, 2026 4:15 PM - SEC Filing Full Article List